Sage Therapeutics, Inc. (SAGE)
USD 5.03
(-4.55%)
USD 5.03
(-4.55%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -540.58 Million | -460.03 Million | -378.18 Million | 664.28 Million | -528.7 Million | -260.67 Million |
| Net Income | -541.48 Million | -532.78 Million | -457.89 Million | 606.07 Million | -680.23 Million | -372.88 Million |
| Depreciation & Amortization | 1.39 Million | 1.12 Million | 4.18 Million | 2.63 Million | 2.28 Million | 1.14 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 73.36 Million | 61.6 Million | 104.62 Million | 95.99 Million | 153.23 Million | 101.96 Million |
| Change in working capital | -67.38 Million | 5.67 Million | -18.5 Million | -39.72 Million | 6.65 Million | 19.21 Million |
| Other non-cash items | -6.47 Million | 4.35 Million | -10.59 Million | -688 Thousand | -10.64 Million | -10.1 Million |
| Investing Cash Flow | 442.91 Million | 325.43 Million | -1 Billion | 442.68 Million | -143.15 Million | -512.46 Million |
| Investments in PPE | -553 Thousand | -937 Thousand | -372 Thousand | -345 Thousand | -5.75 Million | -2.86 Million |
| Acquisitions | -442.91 Million | -326.37 Million | 1 Billion | -443.02 Million | 137.4 Million | - |
| Investment purchases | -594.67 Million | -881.03 Million | -1.99 Billion | -458.72 Million | -1.3 Billion | -1.48 Billion |
| Sales/Maturities of investments | 1.03 Billion | 1.2 Billion | 988.07 Million | 901.74 Million | 1.17 Billion | 974.75 Million |
| Other Investing Activities | 442.91 Million | 326.37 Million | -1 Billion | 443.02 Million | -137.4 Million | -509.6 Million |
| Financing Cash Flow | 6.02 Million | 3.07 Million | 13.33 Million | 426.76 Million | 607.62 Million | 659.35 Million |
| Debt repayment | - | -6.29 Million | -5.73 Million | -6.78 Million | -2.8 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -903 Thousand | -43 Thousand | -1.38 Million | - | -2.17 Million | -904 Thousand |
| Common Stock Issuance | 6.93 Million | 3.11 Million | 14.71 Million | 417.5 Million | 561.27 Million | 631.49 Million |
| Other Financing Activities | 6.93 Million | 9.52 Million | 13.33 Million | 16.05 Million | 51.95 Million | 27.86 Million |
| Accounts receivables | -69.34 Million | 4.84 Million | -18.5 Million | - | - | - |
| Accounts payables | -8.49 Million | 8.43 Million | 6.68 Million | -11.51 Million | -18.78 Million | 24.54 Million |
| Inventory | 69.34 Million | -4.84 Million | 18.5 Million | - | - | - |
| Other working capital | -58.88 Million | -2.76 Million | -6.68 Million | -28.21 Million | 25.44 Million | -5.33 Million |
| Cash at beginning of period | 163.96 Million | 295.5 Million | 1.66 Billion | 129.07 Million | 193.31 Million | 307.08 Million |
| Cash at end of period | 72.32 Million | 163.96 Million | 295.5 Million | 1.66 Billion | 129.07 Million | 193.31 Million |
| Capital Expenditure | -553 Thousand | -937 Thousand | -372 Thousand | -345 Thousand | -5.75 Million | -2.86 Million |
| Effect of forex changes on cash | 540.58 Million | - | - | - | - | - |
| Net cash flow / Change in cash | -91.64 Million | -131.53 Million | -1.36 Billion | 1.53 Billion | -64.23 Million | -113.77 Million |
| Free Cash Flow | -541.13 Million | -460.97 Million | -378.55 Million | 663.93 Million | -534.45 Million | -263.53 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -93.55 Million | -102.85 Million | -108.48 Million | -32.7 Million | -541.48 Million | -201.63 Million |
| Depreciation & Amortization | 255 Thousand | 311 Thousand | 336 Thousand | 409 Thousand | 1.39 Million | 330 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 14.2 Million | 17.16 Million | 13.69 Million | 12.94 Million | 73.36 Million | 28.69 Million |
| Change in working capital | -1.17 Million | 6.98 Million | 58.19 Million | -106.28 Million | -67.38 Million | 41.69 Million |
| Other non-cash items | -2.09 Million | 13 Million | -55.86 Million | 6.12 Million | -6.47 Million | -4.95 Million |
| Investing Cash Flow | 81.05 Million | -386 Thousand | 139.43 Million | 42.06 Million | 442.91 Million | 160.39 Million |
| Investments in PPE | - | - | - | 112 Thousand | -553 Thousand | -328 Thousand |
| Acquisitions | - | - | - | -41.94 Million | -442.91 Million | -160.72 Million |
| Investment purchases | -102.31 Million | -198.31 Million | -61.61 Million | -134.95 Million | -594.67 Million | -70.05 Million |
| Sales/Maturities of investments | 183.37 Million | 197.93 Million | 201.05 Million | 176.9 Million | 1.03 Billion | 230.77 Million |
| Other Investing Activities | - | -386 Thousand | 139.43 Million | 41.94 Million | 442.91 Million | 160.72 Million |
| Financing Cash Flow | 1.03 Million | 8.07 Million | 1.55 Million | -262 Thousand | 6.02 Million | 2.77 Million |
| Debt repayment | - | - | - | -6.81 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 3000.00 | -1000.00 | -2000.00 | -262 Thousand | -903 Thousand | -4000.00 |
| Common Stock Issuance | 1000.00 | 8.18 Million | 1.55 Million | -6.93 Million | 6.93 Million | 2.77 Million |
| Other Financing Activities | 1.03 Million | -118 Thousand | -2000.00 | -262 Thousand | 6.93 Million | 2.77 Million |
| Accounts receivables | -4.92 Million | 566 Thousand | 72.5 Million | -60.49 Million | -69.34 Million | -7.42 Million |
| Accounts payables | -1.52 Million | 2.17 Million | -3.83 Million | -818 Thousand | -8.49 Million | 1.88 Million |
| Inventory | - | - | - | 60.49 Million | 69.34 Million | 7.42 Million |
| Other working capital | 5.27 Million | 4.25 Million | -10.46 Million | -105.46 Million | -58.88 Million | 39.8 Million |
| Cash at beginning of period | 102.73 Million | 173.98 Million | 72.32 Million | 150.04 Million | 163.96 Million | 122.74 Million |
| Cash at end of period | 102.45 Million | 101.23 Million | 173.98 Million | 72.32 Million | 72.32 Million | 150.04 Million |
| Capital Expenditure | - | - | - | 112 Thousand | -553 Thousand | -328 Thousand |
| Effect of forex changes on cash | - | - | - | - | 540.58 Million | - |
| Net cash flow / Change in cash | -274 Thousand | -72.75 Million | 101.66 Million | -77.72 Million | -91.64 Million | 27.29 Million |
| Free Cash Flow | -82.36 Million | -80.43 Million | -37.83 Million | -119.4 Million | -541.13 Million | -136.19 Million |
PVL
PSBKF
7508
0267
7490
IRDM